Alnylam Pharmaceuticals CEO Yvonne Greenstreet discusses the company's development goals and being on the verge of profitability during an interview at the JPM Health-Care Conference in San Francisco. (Source: Bloomberg)
Sign in to read the full article.
Sign in with Google